Application 220016
- Type
- ANDA
- Sponsor
- KLM LABS PVT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MESALAMINE | MESALAMINE | ENEMA;RECTAL | 4GM/60ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220016-001 | MESALAMINE | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220016-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220016-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A220016-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220016-001 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220016-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rowasa | MESALAMINE | Viatris Specialty LLC | e505ab99-1943-4216-a178-4d5dbe64e3b2 | 2026-08-03 | Warnings, Adverse reactions | MESALAMINE |
| mesalamine | MESALAMINE | Major Pharmaceuticals | 14ac4435-903b-41f5-a3c4-8c73de3e4cef | 2026-07-27 | Warnings, Adverse reactions | mesalamine MESALAMINE |
| mesalamine | MESALAMINE | Zydus Pharmaceuticals USA Inc. | ad8c7930-92e2-4372-a874-da22b9ae333e | 2026-07-14 | Warnings, Adverse reactions | mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Sandoz Inc | 47b5d1ee-b439-4ccb-9b01-c0875ccd748a | 2026-06-30 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Nuvaila Limited | 875d573f-99a1-426a-8321-4d511690d503 | 2026-06-03 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | ANI Pharmaceuticals, Inc. | 485ed763-976e-4410-a401-7ff762a931b3 | 2026-05-20 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Lialda | MESALAMINE | Takeda Pharmaceuticals America, Inc. | 3098a080-be86-4265-9818-7fc4beab77b7 | 2026-03-24 | Warnings, Adverse reactions | MESALAMINE |
| Mesalamine | MESALAMINE | Golden State Medical Supply, Inc. | 4c4ffb68-3ca4-35cd-e063-6294a90ab929 | 2026-03-05 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Actavis Pharma, Inc. | 73317da3-cba0-4106-9e88-79b0e2f642af | 2026-02-24 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | AvKARE | 22f3ee49-ac57-84f5-e063-6394a90aae91 | 2026-01-14 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Chartwell RX, LLC | 9703f92d-1d15-4376-8b2b-51502c266012 | 2025-12-17 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| MESALAMINE | MESALAMINE | Camber Pharmaceuticals, Inc. | ef471372-8d9f-4d95-9371-44522c69058f | 2025-12-10 | Warnings, Adverse reactions | MESALAMINE MESALAMINE |
| Mesalamine | MESALAMINE | Rising Pharma Holdings, Inc. | c26ae6cb-041b-4cfc-90ca-c4e1cb23458c | 2025-12-10 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Ingenus Pharmaceuticals, LLC | 58503afe-b8d4-4710-a194-e3acd64ecf1f | 2025-12-05 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Upsher-Smith Laboratories, LLC | 1e6978d0-01db-477d-a90f-27561777480f | 2025-12-01 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Encube Ethicals, Inc. | d6b68275-b2a4-4965-9862-cf14acf8c599 | 2025-10-07 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | American Health Packaging | e638681d-8fca-4bf8-a1fb-8e52357a64da | 2025-05-21 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Actavis Pharma, Inc. | ba1e3bd4-fbe0-46a5-961e-167ccb09672c | 2025-03-27 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Pentasa | MESALAMINE | Takeda Pharmaceuticals America, Inc. | e39d9a3d-5d3a-4bb6-aab1-fdbb2a598606 | 2025-01-15 | Warnings, Adverse reactions | MESALAMINE |
| Mesalamine | MESALAMINE | Northstar Rx LLC. | 7ac78fa0-60a8-48dd-abc4-a487f98039a2 | 2025-01-10 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.